S&P 500 Futures
(0.27%) 5 145.25 points
Dow Jones Futures
(0.29%) 38 551 points
Nasdaq Futures
(0.38%) 17 913 points
Oil
(-0.74%) $83.23
Gas
(1.77%) $1.957
Gold
(-0.23%) $2 341.70
Silver
(1.13%) $27.56
Platinum
(0.72%) $928.70
USD/EUR
(-0.27%) $0.932
USD/NOK
(-0.27%) $10.99
USD/GBP
(-0.35%) $0.798
USD/RUB
(0.65%) $92.47

Realaus laiko atnaujinimai Craneware PLC [CRW.L]

Birža: LSE Pramonė: Health Care Equipment & Services
Atnaujinta26 bal. 2024 @ 18:36

-3.57% £ 2 160.00

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 18:36):

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Chargemaster Toolkit, an automated software-as-a-service (SaaS) chargemaster management solution for capturing optimal legitimate reimbursement for providers; Trisus Supply, a solution that utilizes data to identify data gaps between the systems; Physician Revenue Toolkit, a SaaS solution for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information; Reference Plus, a SaaS solution to perform chargemaster analysis; Pharmacy ChargeLink, a solution to enhance charge capture, pricing, and cost management; integration for chargemaster management, a software that automatically uploads chargemaster changes to the patient billing system for accurate billing; Trisus Pricing Analyzer, a SaaS solution that simplifies the price modelling process; and Online Reference Toolkit and supplies assistant solutions...

Stats
Šios dienos apimtis 47 818.00
Vidutinė apimtis 118 131
Rinkos kapitalizacija 755.25M
EPS £0 ( 2024-03-04 )
Last Dividend £12.50 ( 2023-03-23 )
Next Dividend £0 ( N/A )
P/E 102.86
ATR14 £18.83 (0.86%)

Tūris Koreliacija

Ilgas: -0.04 (neutral)
Trumpas: -0.39 (neutral)
Signal:(45.678) Neutral

Craneware PLC Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
AMGO.L0.957
INVR.L0.955
VINO.L0.951
AVO.L0.949
CRPR.L0.947
APTA.L0.941
HHV.L0.939
MCL.L0.938
WSBN.L0.937
CNS.L0.935
10 Labiausiai neigiamai susiję koreliacijos
JPSA.L-0.96
SMEU.L-0.956
EDIV.L-0.956
RPAB.L-0.956
CLEU.L-0.951
FEDF.L-0.95
FREQ.L-0.949
HEDF.L-0.949
JGSA.L-0.949
XFFE.L-0.948

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Craneware PLC Koreliacija - Valiuta/Žaliavos

The country flag -0.79
( moderate negative )
The country flag -0.78
( moderate negative )
The country flag -0.48
( neutral )
The country flag -0.77
( moderate negative )
The country flag 0.01
( neutral )
The country flag 0.79
( moderate )

Craneware PLC Finansinės ataskaitos

Annual 2022
Pajamos: £174.02M
Bruto pelnas: £148.44M (85.30 %)
EPS: £0.260
FY 2022
Pajamos: £174.02M
Bruto pelnas: £148.44M (85.30 %)
EPS: £0.260
FY 2022
Pajamos: £165.54M
Bruto pelnas: £142.37M (86.00 %)
EPS: £0.270
FY 2021
Pajamos: £75.58M
Bruto pelnas: £70.21M (92.89 %)
EPS: £0.482

Financial Reports:

No articles found.

Craneware PLC Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
£0
(N/A)
£15.50
(N/A)
£12.50
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)

Craneware PLC Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.34 - Stable (13.23%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend £3.10 2008-11-05
Last Dividend £12.50 2023-03-23
Next Dividend £0 N/A
Payout Date 2023-04-14
Next Payout Date N/A
# dividends 31 --
Total Paid Out £254.10 --
Avg. Dividend % Per Year 0.66% --
Score 4.07 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 4.34
Div. Directional Score 8.32 --
Next Divdend (Est)
(2024-06-24)
£0 Estimate 0.00 %
Dividend Stability
0.10 Very Bad
Dividend Score
4.07
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield
2008 £0 0.00%
2009 £0 0.00%
2010 £0 0.00%
2011 £0 0.00%
2012 £0 0.00%
2013 £0 0.00%
2014 £0 0.00%
2015 £0 0.00%
2016 £0 0.00%
2017 £0 0.00%
2018 £24.00 1.31%
2019 £26.00 1.03%
2020 £26.50 1.11%
2021 £27.50 1.26%
2022 £28.00 1.16%
2023 £12.50 0.68%
2024 £0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for LSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
RTC.L Dividend Royal 2023-08-03 Annually 27 157.11%
HINT.L Dividend King 2023-07-27 Quarterly 14 2.44%
BAG.L Dividend Knight 2023-05-11 Annually 32 1.26%
VMUK.L Dividend Junior 2023-05-18 Annually 7 1.91%
MSLH.L Dividend Knight 2023-10-19 Annually 33 1.56%
DOCS.L Dividend Knight 2023-06-08 Semi-Annually 3 1.23%
SIGC.L Dividend Junior 2023-09-14 Semi-Annually 3 0.82%
IMI.L Dividend King 2023-08-10 Semi-Annually 32 1.40%
BOY.L Dividend King 2023-10-05 Semi-Annually 32 1.77%
ORIT.L Dividend Knight 2023-08-17 Quarterly 5 2.77%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.05151.5008.9710.00[0 - 0.5]
returnOnAssetsTTM0.02781.2009.0710.00[0 - 0.3]
returnOnEquityTTM0.06231.500-0.419-0.628[0.1 - 1]
payoutRatioTTM1.202-1.00010.00-10.00[0 - 1]
currentRatioTTM0.7770.800-1.113-0.890[1 - 3]
quickRatioTTM0.6980.800-0.598-0.478[0.8 - 2.5]
cashRatioTTM0.4161.5008.8010.00[0.2 - 2]
debtRatioTTM0.106-1.5008.23-10.00[0 - 0.6]
interestCoverageTTM7.421.0008.368.36[3 - 30]
operatingCashFlowPerShareTTM6.272.007.9110.00[0 - 30]
freeCashFlowPerShareTTM6.242.006.8810.00[0 - 20]
debtEquityRatioTTM0.188-1.5009.25-10.00[0 - 2.5]
grossProfitMarginTTM0.8541.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.1091.0009.829.82[0.1 - 0.6]
cashFlowToDebtRatioTTM3.631.00010.0010.00[0.2 - 2]
assetTurnoverTTM0.5400.8009.747.79[0.5 - 2]
Total Score12.30

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM59.811.0004.060[1 - 100]
returnOnEquityTTM0.06232.50-0.269-0.628[0.1 - 1.5]
freeCashFlowPerShareTTM6.242.007.9210.00[0 - 30]
dividendYielPercentageTTM1.0751.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM6.272.007.9110.00[0 - 30]
payoutRatioTTM1.2021.50010.00-10.00[0 - 1]
pegRatioTTM-109.421.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.7161.00010.000[0.1 - 0.5]
Total Score4.34

Craneware PLC

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Chargemaster Toolkit, an automated software-as-a-service (SaaS) chargemaster management solution for capturing optimal legitimate reimbursement for providers; Trisus Supply, a solution that utilizes data to identify data gaps between the systems; Physician Revenue Toolkit, a SaaS solution for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information; Reference Plus, a SaaS solution to perform chargemaster analysis; Pharmacy ChargeLink, a solution to enhance charge capture, pricing, and cost management; integration for chargemaster management, a software that automatically uploads chargemaster changes to the patient billing system for accurate billing; Trisus Pricing Analyzer, a SaaS solution that simplifies the price modelling process; and Online Reference Toolkit and supplies assistant solutions. It also offers InSight Medical Necessity, a SaaS solution that provides medical necessity validation for the United States payors and advance beneficiary notice creation; Trisus Claims Informatics, a software that automates claim and coding reviews; and InSight Audit, a web-based audit management application for healthcare organizations to manage government and commercial audits. In addition, the company provides Trisus Healthcare Intelligence, a cost analytics and resource efficiency platform; trisus pricing transparency; InSight Denials to analyze, track, trend, and report on denial data; and appeals services. Further, it offers customer success management and consulting services; professional services; and sales and marketing, and product and software development services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.